Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 1:13 pm Sale | 13G | Silence Therapeutics plc SLN | Lombard Odier Asset Management (USA) Corp | 7,992,231 5.700% | -3,645,288 (-31.32%) | View |
| 2024-11-14 09:44 am Sale | 13G | Silence Therapeutics plc SLN | Deep Track Capital LP | 3,000,000 2.140% | -2,854,740 (-48.76%) | View |
| 2024-11-12 4:31 pm Purchase | 13G | Silence Therapeutics plc SLN | Invus Global Management LLC | 8,495,310 6.100% | 156,453 (+1.88%) | View |
| 2024-08-02 6:51 pm Purchase | 13G | Silence Therapeutics plc SLN | Invus Global Management LLC | 8,338,857 6.000% | 8,338,857 (New Position) | View |
| 2024-03-27 5:07 pm Sale | 13D | Silence Therapeutics plc SLN | Griffiths Richard Ian | 23,709,102 16.900% | -5,013,153 (-17.45%) | View |
| 2024-02-14 09:54 am Purchase | 13G | Silence Therapeutics plc SLN | Lombard Odier Asset Management (USA) Corp | 11,637,519 10.400% | 10,317 (+0.09%) | View |
| 2024-02-14 08:55 am Unchanged | 13G | Silence Therapeutics plc SLN | Deep Track Capital LP | 5,854,740 5.430% | 0 (Unchanged) | View |
| 2024-02-12 6:15 pm Sale | 13G | Silence Therapeutics plc SLN | GOLDMAN SACHS GROUP INC GS | 2,316,169 2.200% | -2,224,994 (-49.00%) | View |
| 2024-02-09 5:05 pm Purchase | 13G | Silence Therapeutics plc SLN | Artal International S.C.A. | 9,000,000 7.800% | 1,500,000 (+20.00%) | View |
| 2023-09-01 4:12 pm Purchase | 13G | Silence Therapeutics plc SLN | Artal International S.C.A. | 7,500,000 6.800% | 7,500,000 (New Position) | View |
| 2023-08-14 5:01 pm Purchase | 13D | Silence Therapeutics plc SLN | Griffiths Richard Ian | 28,722,255 26.580% | 1,348,863 (+4.93%) | View |
| 2023-02-14 2:23 pm Purchase | 13G | Silence Therapeutics plc SLN | TCG Crossover GP I LLC | 6,314,625 5.900% | 6,314,625 (New Position) | View |
| 2023-02-14 10:45 am Purchase | 13G | Silence Therapeutics plc SLN | Lombard Odier Asset Management (USA) Corp | 11,627,202 10.800% | 1,209,639 (+11.61%) | View |
| 2023-02-08 3:09 pm Purchase | 13G | Silence Therapeutics plc SLN | GOLDMAN SACHS GROUP INC GS | 4,541,163 5.100% | 4,541,163 (New Position) | View |
| 2022-10-20 4:01 pm Purchase | 13D | Silence Therapeutics plc SLN | Griffiths Richard Ian | 27,373,392 25.420% | 1,904,121 (+7.48%) | View |
| 2022-08-22 4:13 pm Purchase | 13G | Silence Therapeutics plc SLN | Deep Track Capital LP | 5,854,740 5.440% | 5,854,740 (New Position) | View |
| 2022-08-19 4:30 pm Purchase | 13G | Silence Therapeutics plc SLN | TCG Crossover Management LLC | 6,314,625 5.900% | 6,314,625 (New Position) | View |
| 2022-07-20 4:00 pm Purchase | 13D | Silence Therapeutics plc SLN | Griffiths Richard Ian | 25,469,271 28.400% | 1,187,562 (+4.89%) | View |
| 2022-06-15 4:31 pm Purchase | 13D | Silence Therapeutics plc SLN | Griffiths Richard Ian | 24,281,709 27.000% | 3,585,357 (+17.32%) | View |
| 2022-02-14 4:57 pm Sale | 13G | Silence Therapeutics plc SLN | Quested Robert | 7,004,127 7.810% | -616,152 (-8.09%) | View |